A unique molecular chaperone Cosmc required for activity of the mammalian core 1 β3-galactosyltransferase
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Human core 1 β3-galactosyltransferase (C1β3Gal-T) generates the core 1 O-glycan Galβ1-3GalNAcα1-Ser/Thr (T antigen), which is a precursor for many extended O-glycans in animal glycoproteins. We report here that C1β3Gal-T activity requires expression of a molecular chaperone designated Cosmc (co re 1 β3-Gal-T-s pecific m olecular c haperone). The human Cosmc gene is X-linked (Xq23), and its cDNA predicts a 318-aa transmembrane protein (≈36.4 kDa) with type II membrane topology. The human lymphoblastoid T cell line Jurkat, which lacks C1β3Gal-T activity and expresses the Tn antigen GalNAcα1-Ser/Thr, contains a normal gene and mRNA encoding C1β3Gal-T, but contains a mutated Cosmc with a deletion introducing a premature stop codon. Expression of Cosmc cDNA in Jurkat cells restored C1β3Gal-T activity and T antigen expression. Without Cosmc, the C1β3Gal-T is targeted to proteasomes. Expression of active C1β3Gal-T in Hi-5 insect cells requires coexpression of Cosmc. Overexpression of active C1β3Gal-T in mammalian cell lines also requires coexpression of Cosmc, indicating that endogenous Cosmc may be limiting. A small portion of C1β3Gal-T copurifies with Cosmc from cell extracts, demonstrating physical association of the proteins. These results indicate that Cosmc acts as a specific molecular chaperone in assisting the folding/stability of C1β3Gal-T. The identification of Cosmc, a uniquely specific molecular chaperone required for a glycosyltransferase expression in mammalian cells, may shed light on the molecular basis of acquired human diseases involving altered O-glycosylation, such as IgA nephropathy, Tn syndrome, Henoch-Schönlein purpura, and malignant transformation, all of which are associated with a deficiency of C1β3Gal-T activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.7732382 · Cited by 1,583
Setting the Standards: Quality Control in the Secretory Pathway
Ellgaard, L., Molinari, M., & Helenius, A. (1999) · Science · doi:10.1126/science.286.5446.1882 · Cited by 1,192
Chaperone-Mediated Protein Folding
Fink, A. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.2.425 · Cited by 1,053
The purification, composition, and specificity of the anti-T lectin from peanut (Arachis hypogaea).
Lotan, R., Skutelsky, E., Danon, D., & Sharon, N. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40790-4 · Cited by 939
The Copper Chaperone for Superoxide Dismutase
Culotta, V. C., Klomp, L. W. J., Strain, J., Casareno, R. L. B., Krems, B., & Gitlin, J. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23469 · Cited by 850
Retro-translocation of proteins from the endoplasmic reticulum into the cytosol
Tsai, B., Ye, Y., & Rapoport, T. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm780 · Cited by 647
McEver, R. P., & Cummings, R. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119556 · Cited by 641
Self-citationHsp90 & Co. – a holding for folding
Buchner, J. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01373-0 · Cited by 628
Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy
Springer, G. F. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050144 · Cited by 426
Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG
Tomana, M., Matoušovic, K., Julian, B. A., Radl, J., Konecný, K., & Mestecky, J. (1997) · Kidney International · doi:10.1038/ki.1997.361 · Cited by 341
Cloning and Expression of Human Core 1 β1,3-Galactosyltransferase
Ju, T., Brewer, K., D'Souza, A., Cummings, R. D., & Canfield, W. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109060200 · Cited by 290
Self-citationDynamic O-Glycosylation of Nuclear and Cytosolic Proteins
Wells, L., Gao, Y., Mahoney, J. A., Vosseller, K., Chen, C., Rosen, A., & Hart, G. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109656200 · Cited by 246
Glycoproteins and Their Relationship to Human Disease
Brockhausen, I., Schutzbach, J., & Kuhns, W. (1998) · Cells Tissues Organs · doi:10.1159/000046450 · Cited by 190
Stearns-Kurosawa, D. J., Kurosawa, S., Sims, P., Esmon, N. L., & Esmon, C. T. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)35429-8 · Cited by 157
Novogrodsky, A., Lotan, R., Ravid, A., & Sharon, N. (1975) · The Journal of Immunology · doi:10.4049/jimmunol.115.5.1243 · Cited by 146
Biosynthesis of truncated O-glycans in the T cell line Jurkat. Localization of O-glycan initiation.
Piller, V., Piller, F., & Fukuda, M. N. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38842-8 · Cited by 118
Purification, Characterization, and Subunit Structure of Rat Core 1 β1,3-Galactosyltransferase
Ju, T., Cummings, R. D., & Canfield, W. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109056200 · Cited by 117
Self-citationBerger, E. G. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00069-1 · Cited by 115
Progress in Molecular and Genetic Studies of IgA Nephropathy
Novák, J., Julian, B. A., Tomana, M., & Mestecky, J. (2001) · Journal of Clinical Immunology · doi:10.1023/a:1012284402054 · Cited by 113
Enzymatic basis for sialyl-Tn expression in human colon cancer cells
Brockhausen, I., Yang, J., Dickinson, N., Ogata, S., & Itzkowitz, S. H. (1998) · Glycoconjugate Journal · doi:10.1023/a:1006967910803 · Cited by 78
Mucin-type O-glycans and leukosialin
Fukuda, M., & Tsuboi, S. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00067-8 · Cited by 73
O-Glycosylation potential of lepidopteran insect cell lines
Lopez, M., Tétaert, D., Juliant, S., Gazon, M., Cérutti, M., Verbert, A., & Delannoy, P. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(98)00176-7 · Cited by 64
Schneider, U., & Schwenk, H. U. (1977) · Hämatologie und Bluttransfusion · doi:10.1007/978-3-642-66639-1_32 · Cited by 18
Inoue, S., Sano, H., & Ohta, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2170 · Cited by 16
Cited by
Glycosylation in cancer: mechanisms and clinical implications
Pinho, S. S., & Reis, C. A. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3982 · Cited by 3,083
Glycosylation in health and disease
Reily, C., Stewart, T. J., Renfrow, M. B., & Novak, J. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0129-4 · Cited by 2,075
Precision mapping of the human O‐GalNAc glycoproteome through SimpleCell technology
Steentoft, C., Vakhrushev, S. Y., Joshi, H. J., Kong, Y., Vester‐Christensen, M. B., Schjoldager, K. T. G., Lavrsen, K., Dabelsteen, S., Pedersen, N. B., Marcos‐Silva, L., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.79 · Cited by 1,408
The sweet and sour of cancer: glycans as novel therapeutic targets
Fuster, M. M., & Esko, J. D. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1649 · Cited by 1,383
Protein Glycosylation in Cancer
Stowell, S. R., Ju, T., & Cummings, R. D. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040438 · Cited by 873
Self-citation
Metadata
- Authors
- Ju, T., & Cummings, R. D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-12-03
- Volume
- 99
- Issue
- 26
- Pages
- 16613-16618
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2007058211
- Cited by
- 487
- References
- 24
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.